Met Life Investment Management, LLC Insulet Corp Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Insulet Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 21,638 shares of PODD stock, worth $5.63 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
21,638
Previous 21,405
1.09%
Holding current value
$5.63 Million
Previous $4.98 Million
13.39%
% of portfolio
0.03%
Previous 0.03%
Shares
36 transactions
Others Institutions Holding PODD
# of Institutions
753Shares Held
63.1MCall Options Held
467KPut Options Held
639K-
Vanguard Group Inc Valley Forge, PA8.49MShares$2.21 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.45MShares$1.94 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.58 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.97MShares$774 Million0.03% of portfolio
-
Baillie Gifford & CO2.36MShares$613 Million0.49% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.1B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...